Mutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: Involvement in cell fusion and virus entry

Journal of Biomedical Science

Volumn 16, Issue 1, 2009, Pages

  Li, Hsiao Fen ^a   Huang, Chia Hsuan ^a   Ai, Li Shuang ^a   Chuang, Chin Kai ^b   Chen, Steve Sl ^a  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b ANIMAL TECHNOLOGY INSTITUTE TAIWAN   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARAGINE; GLYCOPROTEIN E1; VIRUS FUSION PROTEIN; CD81 ANTIGEN; E1 PROTEIN, HEPATITIS C VIRUS; HYBRID PROTEIN; LEUKOCYTE ANTIGEN; VIRUS ENVELOPE PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CELL FUSION; FLAVIVIRUS; HEPATITIS C VIRUS; MEMBRANE FUSION; NONHUMAN; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS; VIRUS ENTRY; VIRUS INFECTIVITY; AMINO ACID SEQUENCE; CELL SEPARATION; CHEMISTRY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MOLECULAR GENETICS; MUTAGENESIS; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; TUMOR CELL LINE;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ALANINE; AMINO ACID SEQUENCE; ANTIGENS, CD; ASPARAGINE; CELL LINE, TUMOR; CELL SEPARATION; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL ENVELOPE PROTEINS;

EID: 70349973419     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-16-89     Document Type: Article

References (82)

1. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. R Ralston K Thudium K Berger C Kuo B Gervase J Hall M Selby G Kuo M Houghton QL Choo, J Virol 1993 67 6753 6661 8411378
2. Glycosylation of hepatitis C virus envelope proteins. A Goffard J Dubuisson, Biochimie 2003 85 295 301 10.1016/S0300-9084(03)00004-X 12770768 (Pubitemid 36626002)
3. Folding, assembly and subcellular localization of hepatitis C virus glycoproteins. J Dubuisson, Curr Top Microbiol Immunol 2000 242 135 148 10592659
4. Biogenesis of hepatitis C virus envelope glycoproteins. A Op De Beeck L Cocquerel J Dubuisson, J Gen Virol 2001 82 2589 2595 11602769 (Pubitemid 32998636)
5. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Dubuisson HH Hsu RC Cheung HB Greenberg DG Russell CM Rice, J Virol 1994 68 6147 6160 8083956
6. Formation of native hepatitis C virus glycoprotein complexes. V Deleersnyder A Pillez C Wychowski K Blight J Xu Y Hahn C Rice J Dubuisson, J Virol 1997 71 697 704 8985401
7. A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. L Cocquerel J-C Meunier A Pillez C Wychowski J Dubuisson, J Virol 1998 72 2183 2191 9499075 (Pubitemid 28100775)
8. Assembly of a functional HCV glycoprotein heterodimer. M Lavie A Goffard J Dubuisson, Current issues in molecular biology 2007 9 71 86 17489436
9. Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles. RF Clayton A Owsianka J Aitken S Graham D Bhella AH Patel, J Virol 2002 76 7672 7682 10.1128/JVI.76.15.7672-7682. 2002 12097581
10. Interaction between hepatitis C virus core protein and E1 envelope protein. S Lo M Selby J Ou, J Virol 1996 70 5177 5182 8764026
11. Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. TF Baumert S Ito DT Wong TJ Liang, J Virol 1998 72 3827 3836 9557666
12. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotype virus. LM Lagging K Meyer RJ Owens R Ray, J Virol 1998 72 3539 3546 9557633
13. Characterization of pseudotype VSV possessing HCV envelope proteins. Y Matsuura H Tani K Suzuki T Kimura-Someya R Suzuki H Aizaki K Ishii K Moriishi CS Robison MA Whitt T Miyamura, Virology 2001 286 263 275 10.1006/viro.2001.0971 11485395
14. Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins. L Buonocore KJ Blight CM Rice JK Rose, J Virol 2002 76 6865 6872 10.1128/JVI.76.14.6865-6872. 2002 12072487
15. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. B Bartosch J Dubuisson F-L Cosset, J Exp Med 2003 197 633 642 10.1084/jem.20021756 12615904
16. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. B Bartosch G Verney M Dreux P Donot Y Morice F Penin JM Pawlotsky D Lavillette FL Cosset, J Virol 2005 79 8217 8229 10.1128/JVI.79.13.8217-8229.2005 15956567
17. Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein E2 contribute to virus entry. N Callens Y Ciczora B Bartosch N Vu-Dac FL Cosset JM Pawlotsky F Penin J Dubuisson, J Virol 2005 79 15331 15341 10.1128/JVI.79.24.15331-15341.2005 16306604
18. Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. HE Drummer A Maerz P Poumbourios, FEBS Lett 2003 546 385 390 10.1016/S0014-5793(03)00635-5 12832074
19. Hepatitis C virus glycoprotein E2 contains a membrane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization and viral entry. HE Drummer P Poumbourios, J Biol Chem 2004 279 30066 30072 10.1074/jbc.M405098200 15136562
20. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. A Goffard N Callens B Bartosch C Wychowski FL Cosset C Montpellier J Dubuisson, J Virol 2005 79 8400 8409 10.1128/JVI.79.13.8400-8409. 2005 15956584
21. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. M Hsu J Zhang M Flint C Logvinoff C Cheng-Mayer CM Rice JA McKeating, Proc Natl Acad Sci USA 2003 100 7271 7216 10.1073/pnas.0832180100 12761383
22. Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes. D Lavillette B Bartosch D Nourrisson G Verney FL Cosset F Penin EI Pecheur, J Biol Chem 2006 281 3909 3917 10.1074/jbc.M509747200 16356932
23. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. C Voisset N Callens E Blanchard A Op De Beeck J Dubuisson N Vu-Dac, J Biol Chem 2005 280 7793 7799 10.1074/jbc.M411600200 15632171
24. Functional hepatitis C virus envelope glycoproteins. C Voisset J Dubuisson, Biol Cell 2004 96 413 420 10.1016/j.biolcel.2004.03.008 15325070
25. Complete replication of hepatitis C virus in cell culture. BD Lindenbach MJ Evans AJ Syder B Wolk TL Tellinghuisen CC Liu T Maruyama RO Hynes DR Burton JA McKeating CM Rice, Science 2005 309 623 626 10.1126/science.1114016 15947137
26. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. T Wakita T Pietschmann T Kato T Date M Miyamoto Z Zhao K Murthy A Habermann HG Krausslich M Mizokami R Bartenschlager TJ Liang, Nat Med 2005 11 791 796 10.1038/nm1268 15951748
27. Robust hepatitis C virus infection in vitro. J Zhong P Gastaminza G Cheng S Kapadia T Kato DR Burton SF Wieland SL Uprichard T Wakita FV Chisari, Proc Natl Acad Sci USA 2005 102 9294 9299 10.1073/pnas.0503596102 15939869
28. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. M Yi RA Villanueva DL Thomas T Wakita SM Lemon, Proc Natl Acad Sci USA 2006 103 2310 2315 10.1073/pnas.0510727103 16461899
29. Hepatitis C virus entry: potential receptors and their biological functions. L Cocquerel C Voisset J Dubuisson, J Gen Virol 2006 87 1075 1084 10.1099/vir.0.81646-0 16603507
30. Binding of hepatitis C virus to CD81. P Pileri Y Uematsu S Campagnoli G Galli F Falugi R Petracca AJ Weiner M Houghton D Rosa G Grandi S Abrignani, Science 1998 282 938 941 10.1126/science.282.5390.938 9794763
31. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. M Flint C Maidens LD Loomis-Price C Shotton J Dubuisson P Monk A Higginbottom S Levy JA McKeating, J Virol 1999 73 6235 6244 10400713
32. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. E Scarselli H Ansuini R Cerino RM Roccasecca S Acali G Filocamo C Traboni A Nicosia R Cortese A Vitelli, EMBO J 2002 21 5017 5025 10.1093/emboj/cdf529 12356718
33. Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor. V Agnello G Abel M Elfahal GB Knight QX Zhang, Proc Natl Acad Sci USA 1999 96 12766 12771 10.1073/pnas.96.22.12766 10535997
34. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. EG Cormier RJ Durso F Tsamis L Boussemart C Manix WC Olson JP Gardner T Dragic, Proc Natl Acad Sci USA 2004 101 14067 14072 10.1073/pnas.0405695101 15371595
35. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. JP Gardner RJ Durso RR Arrigale GP Donovan PJ Maddon T Dragic WC Olson, Proc Natl Acad Sci USA 2003 100 4498 4503 10.1073/pnas.0831128100 12676990
36. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. PY Lozach H Lortat-Jacob A de Lacroix de Lavalette I Staropoli S Foung A Amara C Houles F Fieschi O Schwartz JL Virelizier F Arenzana-Seisdedos R Altmeyer, J Biol Chem 2003 278 20358 20366 10.1074/jbc.M301284200 12609975
37. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. S Pohlmann J Zhang F Baribaud Z Chen GJ Leslie G Lin A Granelli-Piperno RW Doms CM Rice JA McKeating, J Virol 2003 77 4070 4080 10.1128/JVI.77.7.4070-4080.2003 12634366
38. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. H Barth C Schafer MI Adah F Zhang RJ Linhardt H Toyoda A Kinoshita-Toyoda T Toida TH Van Kuppevelt E Depla F Von Weizsacker HE Blum TF Baumert, J Biol Chem 2003 278 41003 41012 10.1074/jbc.M302267200 12867431
39. Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. B Saunier M Triyatni L Ulianich P Maruvada P Yen LD Kohn, J Virol 2003 77 546 559 10.1128/JVI.77.1.546-559.2003 12477859
40. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. MJ Evans T von Hahn DM Tscherne AJ Syder M Panis B Wolk T Hatziioannou JA McKeating PD Bieniasz CM Rice, Nature 2007 446 801 805 10.1038/nature05654 17325668
41. The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus. L Meertens C Bertaux L Cukierman E Cormier D Lavillette FL Cosset T Dragic, J Virol 2008 82 3555 3560 10.1128/JVI.01977-07 18234789
42. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. S Liu W Yang L Shen JR Turner CB Coyne T Wang, J Virol 2009 83 2011 2014 10.1128/JVI.01888-08 19052094
43. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. A Ploss MJ Evans VA Gaysinskaya M Panis H You YP de Jong CM Rice, Nature 2009 457 882 886 10.1038/nature07684 19182773
44. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. D Lavillette Y Morice G Germanidis P Donot A Soulier E Pagkalos G Sakellariou L Intrator B Bartosch JM Pawlotsky FL Cosset, J Virol 2005 79 6023 6034 10.1128/JVI.79.10.6023-6034.2005 15857988
45. Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system. J Corver A Ortiz SL Allison J Schalich FX Heinz J Wilschut, Virology 2000 269 37 46 10.1006/viro.1999.0172 10725196
46. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. S Bressanelli K Stiasny SL Allison EA Stura S Duquerroy J Lescar FX Heinz FA Rey, EMBO J 2004 23 728 738 10.1038/sj.emboj. 7600064 14963486
47. Differences between cell membrane fusion activities of two dengue type-1 isolates reflect modifications of viral structure. P Despres MP Frenkiel V Deubel, Virology 1993 196 209 219 10.1006/viro.1993.1469 8356794
48. Structure of West Nile virus. S Mukhopadhyay BS Kim PR Chipman MG Rossmann RJ Kuhn, Science 2003 302 248 10.1126/science.1089316 14551429
49. pH-dependent fusion between the flavivirus West Nile and liposomal model membranes. SW Gollins JS Porterfield, J Gen Virol 1986 67 157 166 10.1099/0022-1317-67-1-157 3944582
50. Virus membrane-fusion proteins: more than one way to make a hairpin. M Kielian FA Rey, Nat Rev Microbiol 2006 4 67 76 10.1038/nrmicro1326 16357862
51. Proteolytic activation of tick-borne encephalitis virus by furin. K Stadler SL Allison J Schalich FX Heinz, J Virol 1997 71 8475 8481 9343204
52. Cell-associated West Nile flavivirus is covered with E?M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release. G Wengler, J Virol 1989 63 2521 2526 2724410
53. A structural perspective of the flavivirus life cycle. S Mukhopadhyay RJ Kuhn MG Rossmann, Nat Rev Microbiol 2005 3 13 22 10.1038/nrmicro1067 15608696
54. A model for the hepatitis C virus envelope glycoprotein E2. AT Yagnik A Lahm A Meola RM Roccasecca BB Ercole A Nicosia A Tramontano, Proteins 2000 40 355 366 10.1002/1097-0134(20000815)40:3<355::AID-PROT203.0.CO;2-K 10861927
55. The fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. J Lescar A Roussel MW Wien J Navaza SD Fuller G Wengler FA Rey, Cell 2001 105 137 148 10.1016/S0092-8674(01)00303-8 11301009
56. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. M Flint JM Thomas CM Maidens C Shotton S Levy WS Barclay JA McKeating, J Virol 1999 73 6782 6790 10400776
57. Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins. RF Garry S Dash, Virology 2003 307 255 265 10.1016/S0042-6822(02)00065-X 12667795
58. Fusion peptides and the mechanism of viral fusion. RM Epand, Biochimica et biophysica acta 2003 1614 116 121 10.1016/S0005-2736(03)00169-X 12873772
59. Viral fusion proteins: multiple regions contribute to membrane fusion. SG Peisajovich Y Shai, Biochimica et biophysica acta 2003 1614 122 129 10.1016/S0005-2736(03)00170-6 12873773
60. Membrane-perturbing properties of three peptides corresponding to the ectodomain of hepatitis C virus E2 envelope protein. B Pacheco J Gomez-Gutierrez B Yelamos C Delgado F Roncal JP Albar D Peterson F Gavilanes, Biochimica et biophysica acta 2006 1758 755 763 10.1016/j.bbamem.2006.04.024 16777058
61. Interaction of the most membranotropic region of the HCV E2 envelope glycoprotein with membranes: Biophysical characterization. AJ Perez-Berna J Guillen MR Moreno AI Gomez-Sanchez G Pabst P Laggner J Villalain, Biophysical journal 2008 94 4737 4750 10.1529/biophysj.107.126896 18339752
62. The membrane-active regions of the hepatitis C virus E1 and E2 envelope glycoproteins. AJ Perez-Berna MR Moreno J Guillen A Bernabeu J Villalain, Biochemistry 2006 45 3755 3768 10.1021/bi0523963 16533059
63. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. D Lavillette EI Pecheur P Donot J Fresquet J Molle R Corbau M Dreux F Penin FL Cosset, J Virol 2007 81 8752 8765 10.1128/JVI.02642-06 17537855
64. Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1. HE Drummer I Boo P Poumbourios, J Gen Virol 2007 88 1144 1148 10.1099/vir.0.82567-0 17374757
65. A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. L Cocquerel JC Meunier A Pillez C Wychowski J Dubuisson, J Virol 1998 72 2183 2191 9499075 (Pubitemid 28100775)
66. Effect of extension of the cytoplasmic domain of human immunodeficiency type 1 virus transmembrane protein gp41 on virus replication. W-E Chan Y-L Wang H-H Lin SS Chen, J Virol 2004 78 5157 5169 10.1128/JVI.78.10.5157-5169.2004 15113898
67. Characterization of functional hepatitis C virus envelope glycoproteins. A Op De Beeck C Voisset B Bartosch Y Ciczora L Cocquerel Z Keck S Foung F-L Cosset J Dubuisson, J Virol 2004 78 2994 3002 10.1128/JVI.78.6.2994-3002.2004 14990718
68. CD81 associates with 14-3-3 in a redox-regulated palmitoylation-dependent manner. KL Clark A Oelke ME Johnson KD Eilert PC Simpson SC Todd, J Biol Chem 2004 279 19401 19406 10.1074/jbc.M312626200 14966136
69. Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of the severe acute respiratory syndrome coronavirus. WE Chan CK Chuang SH Yeh MS Chang SS Chen, J Virol 2006 80 3225 3237 10.1128/JVI.80.7.3225-3237. 2006 16537590
70. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J He S Choe R Walker P Di Marzio DO Morgan NR Landau, J Virol 1995 69 6705 6711 7474080
71. Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity. SS Chen AA Ferrante EF Terwilliger, Virology 1996 226 260 268 10.1006/viro.1996.0654 8955046
72. Effect of point mutations in the N terminus of the lentivirus lytic peptide-1 sequence of human immunodeficiency virus type 1 transmembrane glycoprotein gp41 on Env stability. SF Lee CY Ko CT Wang SS Chen, J Biol Chem 2002 277 15363 15375 10.1074/jbc.M201479200 11859090
73. Mutations in the leucine zipper-like heptad repeat sequence of human immunodeficiency virus type 1 gp41 dominantly interfere with wild-type virus infectivity. SS Chen SF Lee HJ Hao CK Chuang, J Virol 1998 72 4765 4774 9573241
74. Cell fusion activity of hepatitis C virus envelope proteins. S Takikawa K Ishii H Aizaki T Suzuki H Asakura Y Matsuura T Miyamura, J Virol 2000 74 5066 5074 10.1128/JVI.74.11.5066-5074.2000 10799580
75. Characterization of the putative fusogenic domain in vesicular stomatitis virus glycoprotein G. L Zhang H Ghosh, J Virol 1994 68 2186 2193 8139003
76. Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins. M Flint C Logvinoff CM Rice JA McKeating, J Virol 2004 78 6875 6882 10.1128/JVI.78.13.6875-6882.2004 15194763
77. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. O Nussbaum C Broder E Berger, J Virol 1994 68 5411 5422 8057423
78. Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. M Pizzato SA Marlow ED Blair Y Takeuchi, J Virol 1999 73 8599 8611 10482613
79. A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry. HE Drummer I Boo AL Maerz P Poumbourios, J Virol 2006 80 7844 7853 10.1128/JVI.00029-06 16873241
80. Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding. AM Owsianka JM Timms AW Tarr RJ Brown TP Hickling A Szwejk K Bienkowska-Szewczyk BJ Thomson AH Patel JK Ball, J Virol 2006 80 8695 8704 10.1128/JVI.00271-06 16912317
81. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. FA Rey FX Heinz C Mandl C Kunz SC Harrison, Nature 1995 375 291 298 10.1038/375291a0 7753193
82. Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. DL Gibbons MC Vaney A Roussel A Vigouroux B Reilly J Lepault M Kielian FA Rey, Nature 2004 427 320 325 10.1038/nature02239 14737160 (Pubitemid 38133653)